Halo Labs Inc. has acquired private company Precisa Medical Instruments Corp. for 13,392,857 Halo shares valued at 28 Canadian cents apiece.
Switzerland-based Precisa's product portfolio includes the Accu-Dab cannabinoid oil delivery system, used to take measured doses of the oil for oral consumption.
In June, Halo signed a nonbinding letter of intent to acquire Lesotho-based Bophelo Bioscience & Wellness (Pty.) Ltd.
Toronto-based Halo Labs manufactures cannabis oils and concentrates and operates in the U.S.